RenovoRx Inc. (RNXT)
RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth
RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth
📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive financial catalyst • High potential for stock growth **Sentiment:** Positive (95%) **Content type:** Financial